Tagged With Vaccine Trials

When experts say COVID-19 vaccines are 95% effective it doesn't mean you still have a 5% chance of getting sick


I participated in the AstraZeneca trial in the UK. I dropped out after learning they were collaborating with Russia's Sputnik vaccine.


I'm a neurologist who happily volunteered for the AstraZeneca vaccine trials. Here's what people are getting wrong about the process.



The Pfizer and AstraZeneca COVID-19 shots will be combined in a 'mix and match' trial to see if the 2 vaccines together produce a stronger immune response


Top economists and 2 former 2020 presidential candidates are backing a 'vaccine stimulus' that would pay people at least $1,000 to get COVID-19 shots


China's Sinopharm has applied for regulatory approval to launch a COVID-19 vaccine for public use, but nearly 1 million people have already taken experimental shots



AstraZeneca will likely retest its COVID-19 vaccine, CEO says after admitting an error in the first trial that may have skewed results


AstraZeneca admits the best results in its COVID-19 vaccine study came from a dosing error, and experts are raising new questions about the shot


Vaccine trials didn't monitor one variable: volunteers' behaviour. 'Masks and social distancing were left up to us,' a participant said.


When experts say COVID-19 vaccines are 95% effective it doesn't mean you'd have a 5% chance of getting sick


US stocks resume climb as investors cheer COVID-19 vaccine progress


Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval



Pfizer vaccine-trial participant reveals what it's like to volunteer for research that helped create the first effective COVID-19 vaccine


Fauci predicts good results from Moderna's COVID-19 vaccine trial because it's similar to Pfizer's, but warns against declaring victory


The EU's drug regulator would reportedly approve a COVID-19 vaccine even if it worked in less than 50% of people — a lower threshold than the FDA


AstraZeneca's COVID-19 vaccine produces an immune response in older people, raising hopes a vaccine will protect those at greatest risk



Remdesivir, the only antiviral authorised for COVID-19 in the US, did not improve chances of survival in a massive WHO study


Goldman Sachs says sell the dollar due to the increasing odds of a Biden-led blue wave and progress on COVID-19 vaccine


I volunteered to test the Moderna coronavirus vaccine. Here's what the side effects were like, and why I want my experience to give people hope.


Trump's experimental treatment from Regeneron puts the company in a 'very tough situation' as others request early access, CEO says